232 related articles for article (PubMed ID: 36174040)
1. Regulation of Parkinson's disease-associated genes by Pumilio proteins and microRNAs in SH-SY5Y neuronal cells.
Snoderly-Foster LJ; Olivas WM
PLoS One; 2022; 17(9):e0275235. PubMed ID: 36174040
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.
Tagliafierro L; Glenn OC; Zamora ME; Beach TG; Woltjer RL; Lutz MW; Chiba-Falek O
Alzheimers Dement; 2017 Nov; 13(11):1237-1250. PubMed ID: 28431219
[TBL] [Abstract][Full Text] [Related]
3. A single nucleotide polymorphism in the 3'UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease.
Sotiriou S; Gibney G; Baxevanis AD; Nussbaum RL
Neurosci Lett; 2009 Sep; 461(2):196-201. PubMed ID: 19540308
[TBL] [Abstract][Full Text] [Related]
4. Discovering the 3' UTR-mediated regulation of alpha-synuclein.
Marchese D; Botta-Orfila T; Cirillo D; Rodriguez JA; Livi CM; Fernández-Santiago R; Ezquerra M; Martí MJ; Bechara E; Tartaglia GG;
Nucleic Acids Res; 2017 Dec; 45(22):12888-12903. PubMed ID: 29149290
[TBL] [Abstract][Full Text] [Related]
5. Variants in the 3'UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression.
Schmitt I; Wüllner U; van Rooyen JP; Khazneh H; Becker J; Volk A; Kubisch C; Becker T; Kostic VS; Klein C; Ramirez A
Eur J Hum Genet; 2012 Dec; 20(12):1265-9. PubMed ID: 22617348
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus.
Tatura R; Kraus T; Giese A; Arzberger T; Buchholz M; Höglinger G; Müller U
Parkinsonism Relat Disord; 2016 Dec; 33():115-121. PubMed ID: 27717584
[TBL] [Abstract][Full Text] [Related]
7. SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder.
Toffoli M; Dreussi E; Cecchin E; Valente M; Sanvilli N; Montico M; Gagno S; Garziera M; Polano M; Savarese M; Calandra-Buonaura G; Placidi F; Terzaghi M; Toffoli G; Gigli GL
Neurol Sci; 2017 Jul; 38(7):1233-1240. PubMed ID: 28409245
[TBL] [Abstract][Full Text] [Related]
8. A novel extended form of alpha-synuclein 3'UTR in the human brain.
Je G; Guhathakurta S; Yun SP; Ko HS; Kim YS
Mol Brain; 2018 May; 11(1):29. PubMed ID: 29801501
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-599 regulates the development of Parkinson's disease through mediating LRRK2 expression.
Wu Q; Xi DZ; Wang YH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):724-731. PubMed ID: 30720180
[TBL] [Abstract][Full Text] [Related]
10. Modulation of TRPV1 and TRPA1 Channels Function by Sea Anemones' Peptides Enhances the Viability of SH-SY5Y Cell Model of Parkinson's Disease.
Kolesova YS; Stroylova YY; Maleeva EE; Moysenovich AM; Pozdyshev DV; Muronetz VI; Andreev YA
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203538
[TBL] [Abstract][Full Text] [Related]
11. Blood RNA biomarkers in prodromal PARK4 and rapid eye movement sleep behavior disorder show role of complexin 1 loss for risk of Parkinson's disease.
Lahut S; Gispert S; Ömür Ö; Depboylu C; Seidel K; Domínguez-Bautista JA; Brehm N; Tireli H; Hackmann K; Pirkevi C; Leube B; Ries V; Reim K; Brose N; den Dunnen WF; Johnson M; Wolf Z; Schindewolf M; Schrempf W; Reetz K; Young P; Vadasz D; Frangakis AS; Schröck E; Steinmetz H; Jendrach M; Rüb U; Başak AN; Oertel W; Auburger G
Dis Model Mech; 2017 May; 10(5):619-631. PubMed ID: 28108469
[TBL] [Abstract][Full Text] [Related]
12. YY1 binds to α-synuclein 3'-flanking region SNP and stimulates antisense noncoding RNA expression.
Mizuta I; Takafuji K; Ando Y; Satake W; Kanagawa M; Kobayashi K; Nagamori S; Shinohara T; Ito C; Yamamoto M; Hattori N; Murata M; Kanai Y; Murayama S; Nakagawa M; Toda T
J Hum Genet; 2013 Nov; 58(11):711-9. PubMed ID: 24026176
[TBL] [Abstract][Full Text] [Related]
13. LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p/alpha-synuclein axis in Parkinson's disease.
Zhang J; Yang Y; Zhou C; Zhu R; Xiao X; Zhou B; Wan D
Bioengineered; 2022 Feb; 13(2):4493-4516. PubMed ID: 35137671
[TBL] [Abstract][Full Text] [Related]
14. Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA.
Zhang P; Park HJ; Zhang J; Junn E; Andrews RJ; Velagapudi SP; Abegg D; Vishnu K; Costales MG; Childs-Disney JL; Adibekian A; Moss WN; Mouradian MM; Disney MD
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1457-1467. PubMed ID: 31900363
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of miR-34b and miR-34c enhances α-synuclein expression in Parkinson's disease.
Kabaria S; Choi DC; Chaudhuri AD; Mouradian MM; Junn E
FEBS Lett; 2015 Jan; 589(3):319-25. PubMed ID: 25541488
[TBL] [Abstract][Full Text] [Related]
16. Microarray expression analysis of human dopaminergic neuroblastoma cells after RNA interference of SNCA--a key player in the pathogenesis of Parkinson's disease.
Häbig K; Walter M; Stappert H; Riess O; Bonin M
Brain Res; 2009 Feb; 1256():19-33. PubMed ID: 19135032
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein.
Valente T; Dentesano G; Ezquerra M; Fernandez-Santiago R; Martinez-Martin J; Gallastegui E; Domuro C; Compta Y; Martí MJ; Bachs O; Márquez-Kisinousky L; Straccia M; Solà C; Saura J
Cell Death Differ; 2020 Feb; 27(2):509-524. PubMed ID: 31209363
[TBL] [Abstract][Full Text] [Related]
18. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
[TBL] [Abstract][Full Text] [Related]
19. Manganese exposure: Linking down-regulation of miRNA-7 and miRNA-433 with α-synuclein overexpression and risk of idiopathic Parkinson's disease.
Tarale P; Daiwile AP; Sivanesan S; Stöger R; Bafana A; Naoghare PK; Parmar D; Chakrabarti T; Krishnamurthi K
Toxicol In Vitro; 2018 Feb; 46():94-101. PubMed ID: 28986288
[TBL] [Abstract][Full Text] [Related]
20. Inclusion of a portion of the native SNCA 3'UTR reduces toxicity of human S129A SNCA on striatal-projecting dopamine neurons in rat substantia nigra.
Khodr CE; Pedapati J; Han Y; Bohn MC
Dev Neurobiol; 2012 Jun; 72(6):906-17. PubMed ID: 22021082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
